Pelthos Therapeutics PTHS
NYSE PTHS
$17.02 -2.77 (-14.00%)
At close: Oct 23, 2026 · 4:00 PM EDT

Pelthos Therapeutics (PTHS) Return on Sales [ROS] (2025 - 2026)

Updated

Pelthos Therapeutics (PTHS) recorded Return on Sales [ROS] of -111.02% in Q2 2026, up 8.98 percentage points from the prior quarter.

Analysis

Pelthos Therapeutics (PTHS) Return on Sales [ROS] (2025 - 2026) Analysis & Trends

On a TTM basis, Pelthos Therapeutics' Return on Sales [ROS] came in at -133.42% as of Jun 30, 2026; for FY2025, it came in at -193.09%.

  • Per Business Quant, the preceding three quarters came in at -120.01% (Q1 2026), -127.84% (Q4 2025) and -207.43% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 24.35%
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 37.86%
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -3.52%
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 32.97%
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 20.57%
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 34.95%
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -133.21%
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 28.37%
10 Pelthos Therapeutics 63.29 Mn -25.10 Mn 11.99 Mn -111.02%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -111.02%
Mar 31, 2026 -120.01%
Dec 31, 2025 -127.84%
Sep 30, 2025 -207.43%
API Access

Pelthos Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=PTHS&period=max&api_key=YOUR_API_KEY